Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report) passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.36 and traded as high as $0.3614. Elite Pharmaceuticals shares last traded at $0.3570, with a volume of 1,348,359 shares.
Elite Pharmaceuticals Trading Up 3.8%
The stock’s fifty day simple moving average is $0.36 and its 200-day simple moving average is $0.43. The firm has a market cap of $384.54 million, a PE ratio of 11.90 and a beta of 0.38. The company has a debt-to-equity ratio of 0.05, a current ratio of 7.34 and a quick ratio of 5.44.
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.
Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.
Further Reading
- Five stocks we like better than Elite Pharmaceuticals
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
